News and Comments

Like Dendreon (DNDN) Human Genome might have Bottomed

  Monday, January 09, 2012

As expected, Human Genome Sciences (HGSI) will report on progress with the commercialization of Benlysta® (belimumab) during a presentation at the 30th Annual JPMorgan Healthcare Conference in San Francisco. The drug is approved for the treatment of adult patients with active autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy. More...

VERTEX (VRTX): At the Finish Line

  Monday, August 09, 2010

When an investigational drug proves it can eradicate a virus we call it a breakthrough. The nearest to approval of the expected breakthroughs is Vertex’ (VRTX) drug telaprevir, a specific hepatitis C virus protease inhibitor. The drug was a blessing for the infected victims who had it in clinical trials. It brought a miracle happy ending to what seemed to be an endless nightmare of acute liver inflammation, chronic liver inflammation, liver cirrhosis, liver transplant and possible liver cancer. We expected telaprevir to be greeted by the government and insurance companies, which spend ton of money on the HCV liver problems where treatments that do not work are, nevertheless, paid for.  More...


Recent Postings


Archive


Tags

Inovio (INO) KITE (KITE) Advaxis (ADXS) Dendreon (DNDN) C4 Therapeutics Intercept (ICPT) Bellicum (BLCM) Idenix (IDIX) Sanofi (SNY) Anadys (ANDS) Prolor Biotech (PBTH) AGOS (ARGS) Merck (MRK) RenenxBio (RGNX) ZALTRAP™ PTC Therapeutics (PTCT) Mirati Therapeutics (MRTX) Agenus (AGEN Benlysta (belimumab) Alder Biopharmaceuticals (ALDR) Regeneron (REGN) Alnylam (ALNY) Ziofpharm (ZIOP) Vitae Pharmaceuticals (VTAE) GUARDIAN HEALTH VANDA (VNDA) SERES THERAPEUTICS (MCRB) ACADIA (ACAD) CompuGen (CGEN) Human Genome Sciences (HGSI) Amgen (AMGN) Theravance (THRX) NEKTAR (NKTR)) Pluristem (PSTI) Sarepta (SRPT) AERIE PHARMACEUTICALS SUNESIS PHARMACEUTICALS (SNSS) Genentech KERYX (KERX) NOVOCURE (NVCR) ADVENTRIX (ANX) Velcade (bortezomib) Rapamune Sequenom (SQNM) Trastuzumab-DM1 Intermune (ITMN) GlaxoSmithKline (GSK) Roche (ROCHE) Agenus (AGEN) ARGOS (ARGS) Telaprevir Illumina (ILMN) Anacor (ANAC) Array Pharmaceuticals (ARRY) Seattle Genetics (SGEN) Onyx (ONXX) Ridaforolimus Spike Therapeutics (ONCE) Theravance Bio Pharma (TBPH) Cytokinetics (CYTK) Multiple Myeloma Vertex (VRTX) Adaptimmune (ADAP) Editas (EDIT) SYNTA (SNTA) MODERNA HALOZYME (HALO) Auspex (ASPX) Intrexon (XON) ImmunoGen (IMGN) Dynavax (DVAX) Bristol-Myers Squibb (BMY) Abbott Laboratories (ABT) REGULUS (RGLS) Zerenex Sangamo (SGMO) Roche (RHHBY) Global Cell Therapeutics (GBT) ABBVIE (ABBV) Prosensa (RNA) Exelixis (EXEL) Elan (ELN) Sanofi (SNA) Human Longevity (HLI) Gilead (GILD) AstraZeneca (AZN) Incyte (INCY) galapagos (GLPG) IDERA (IDRA) OSI (OSIP) TOKAI (TKAOI) INNOVIVA (INVA) JUNO (JUNO) Xoma (XOMA) Endometrial Cancer Jazz Pharmaceuticals (JAZZ) Valeant Pharmaceuticals International (VRX) ISIS (ISIS) Biocryst (BCRX) Biogen Idec (BIIB) Micromet (MITI) ARCA (ABIO) Sanofi-Aventis (SAN) Herceptin Galena (GALE) BIOMARIN (BMRN) Ariad (ARIA) Revlimid (lenolidamide) NANTKWEST (NK) Aimmune Therapeutics (AIMT) Tysabri Ionis (IONS)